| Literature DB >> 23891656 |
Sumit Parikh1, Amy Goldstein2, Mary Kay Koenig3, Fernando Scaglia4, Gregory M Enns5, Russell Saneto6, Irina Anselm, Abigail Collins, Bruce H Cohen, Suzanne D DeBrosse, David Dimmock, Marni J Falk, Jaya Ganesh, Carol Greene, Andrea L Gropman, Richard Haas, Stephen G Kahler, John Kamholz, Fran Kendall, Mark S Korson, Andre Mattman, Margherita Milone, Dmitriy Niyazov, Phillip L Pearl, Tyler Reimschisel, Ramona Salvarinova-Zivkovic, Katherine Sims, Mark Tarnopolsky, Chang-Yong Tsao, Johan van Hove, Laurence Walsh, Lynne A Wolfe.
Abstract
Mitochondrial medicine is a young subspecialty. Clinicians have a limited evidence base on which to formulate clinical decisions regarding diagnosis, treatment and patient management. Mitochondrial medicine specialists have cobbled together an informal set of rules and paradigms for preventive care and management based in part on anecdotal experience. The Mitochondrial Medicine Society (MMS) assessed the current state of clinical practice from diagnosis, to preventive care and treatment, as provided by various mitochondrial disease specialists in North America. We hope that by obtaining this information we can begin moving towards formulating a set of consensus criteria and establishing standards of care.Entities:
Keywords: Clinical guidelines; Mitochondrial disease; Mitochondrial medicine
Mesh:
Year: 2013 PMID: 23891656 DOI: 10.1016/j.mito.2013.07.116
Source DB: PubMed Journal: Mitochondrion ISSN: 1567-7249 Impact factor: 4.160